Related Experiment Video
Updated: Jun 20, 2025
05:05
Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
12.2K
Malignant glaucoma treated by low-dose laser cycloplasty: a 1-year multicenter prospective non-comparative study
Hai-Shuang Lin1, Xiao-Ping Xu2, Xuan-Li Zheng1
1Wenzhou Medical University, Wenzhou 325027, Zhejiang Province, China.
International Journal of Ophthalmology
|July 19, 2024
Summary
Low-dose laser cycloplasty (LCP) effectively reformed the anterior chamber in malignant glaucoma patients, significantly reducing intraocular pressure and medication needs over one year. While initial success was high, a 12-month success rate of 64.3% was observed due to some relapses.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Surgical Interventions
Background:
- Malignant glaucoma is a severe form of angle-closure glaucoma.
- Reforming the anterior chamber is crucial for managing malignant glaucoma.
- Low-dose laser cycloplasty (LCP) is a potential treatment modality.
Purpose of the Study:
- To evaluate the one-year clinical outcomes of low-dose laser cycloplasty (LCP).
- To assess the efficacy and safety of LCP in patients with malignant glaucoma.
Main Methods:
- Prospective, multicenter, non-comparative clinical study.
- 34 eyes with malignant glaucoma underwent LCP.
- Follow-up included IOP, medication use, anterior chamber depth, and complications at 1 week, and 1, 3, 6, 12 months.
Main Results:
- Mean IOP decreased from 36.1±11.5 mmHg to 17.4±6.7 mmHg at 12 months (P<0.001).
- Glaucoma medication use decreased significantly.
- Initial anatomical success was 94.1%, with a 12-month success rate of 64.3% after accounting for relapses.
- Complications included anterior synechia, choroidal/ciliary detachment, and hypopyon.
Conclusions:
- Low-dose laser cycloplasty (LCP) is a simple, safe, and effective procedure.
- LCP successfully reforms the anterior chamber in malignant glaucoma patients.
- Long-term efficacy requires monitoring due to potential relapses.
Related Concept Videos
01:28Angle Closure Glaucoma: Treatment
468
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
468
01:27Open Angle Glaucoma: Treatment
422
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
422
01:25Glaucoma: Overview
536
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
536